Rare diseases
Investigational molecules
Locations
Ruddershove 10, 8000 Brugge, Belgium
The clinical research activity is centered on coronary artery disease, with attention to patients receiving care after percutaneous coronary intervention. The sponsor’s trial portfolio reflects interest in reducing major cardiovascular events and improving outcomes in established coronary artery disease.
Research activity is focused on clinical endpoints relevant to long-term cardiovascular risk, including death, non-fatal myocardial infarction, non-fatal stroke, and repeat coronary procedures.
Az St-Jan Brugge-Oostende A.V. runs clinical trials in conditions such as Coronary artery disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
